Evopoint Biosciences Co., Ltd. (SHA:688837)
36.67
-1.04 (-2.76%)
Oct 23, 2026, 11:29 AM CST
Evopoint Biosciences Market Cap
Evopoint Biosciences has a market cap or net worth of 15.97 billion as of October 22, 2026. It is the 5,923rd most valuable company in the world and the 995th biggest in China.
Market Cap
15.97B
Enterprise Value
16.28B
Revenue
1.11B
Global Rank
Country Rank
#995 China
PE Ratio
33.19
ChartMarket Cap Chart
Since September 16, 2026, Evopoint Biosciences's market cap has decreased from 17.50B to 15.97B, a decrease of -8.74%. That is a compound annual growth rate of -59.41%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2026 | 15.97B | -2.76% |
| Oct 22, 2026 | 16.42B | -5.23% |
| Oct 21, 2026 | 17.33B | -1.17% |
| Oct 20, 2026 | 17.53B | -1.15% |
| Oct 19, 2026 | 17.74B | 6.07% |
| Oct 16, 2026 | 16.72B | -7.27% |
| Oct 15, 2026 | 18.03B | -4.80% |
| Oct 14, 2026 | 18.94B | 1.16% |
| Oct 13, 2026 | 18.73B | -1.83% |
| Oct 12, 2026 | 19.07B | -7.30% |
| Oct 9, 2026 | 20.58B | -4.74% |
| Oct 8, 2026 | 21.60B | 0.40% |
| Sep 30, 2026 | 21.51B | 13.28% |
| Sep 29, 2026 | 18.99B | -3.24% |
| Sep 28, 2026 | 19.63B | -4.73% |
| Sep 24, 2026 | 20.60B | -11.74% |
| Sep 23, 2026 | 23.34B | 1.36% |
| Sep 22, 2026 | 23.03B | -13.03% |
| Sep 21, 2026 | 26.48B | 9.35% |
| Sep 18, 2026 | 24.21B | 34.46% |
| Sep 17, 2026 | 18.01B | 2.91% |
| Sep 16, 2026 | 17.50B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Hualan Biological Engineering | 23.72B |
| Hebei Changshan Biochemical Pharmaceutical | 18.52B |
| Xiamen Amoytop Biotech | 18.50B |
| Yili Chuanning Biotechnology | 17.79B |
| Acrobiosystems | 16.34B |
| Sinocelltech Group | 15.66B |
| HitGen | 15.10B |
| BrightGene Bio-Medical Technology | 13.80B |